Keywords: phase, ii, results, amylin, ac137, pharmaceuticals, presented

PHASE II RESULTS WITH AMYLIN'S AC137

Article | 20 June 1994

Print This

Amylin Pharmaceuticals has presented interim Phase II data from several ongoing studies of tripro-amylin (AC137) which suggest that the agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in